Bio Rad Laboratories Inc
NYSE:BIO.B

Watchlist Manager
Bio Rad Laboratories Inc Logo
Bio Rad Laboratories Inc
NYSE:BIO.B
Watchlist
Price: 250.08 USD
Market Cap: 7.3B USD

Wall Street
Price Targets

BIO.B Price Targets Summary
Bio Rad Laboratories Inc

Wall Street analysts forecast BIO.B stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIO.B is 363.55 USD with a low forecast of 329.56 USD and a high forecast of 395.33 USD.

Lowest
Price Target
329.56 USD
32% Upside
Average
Price Target
363.55 USD
45% Upside
Highest
Price Target
395.33 USD
58% Upside
Bio Rad Laboratories Inc Competitors:
Price Targets
CTKB
Cytek Biosciences Inc
15% Upside
2269
WuXi Biologics (Cayman) Inc
27% Upside
603127
Joinn Laboratories China Co Ltd
31% Downside
TECH
Bio-Techne Corp
21% Upside
EVT
Evotec SE
66% Upside
MRVI
Maravai LifeSciences Holdings Inc
20% Upside
TXG
10X Genomics Inc
9% Upside
ONT
Oxford Nanopore Technologies PLC
64% Upside

Revenue
Forecast

Revenue Estimate
Bio Rad Laboratories Inc

For the last 13 years the compound annual growth rate for Bio Rad Laboratories Inc's revenue is 2%. The projected CAGR for the next 4 years is 1%.

2%
Past Growth
1%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bio Rad Laboratories Inc

For the last 13 years the compound annual growth rate for Bio Rad Laboratories Inc's operating income is 0%. The projected CAGR for the next 3 years is 7%.

0%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Bio Rad Laboratories Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIO.B's stock price target?
Price Target
363.55 USD

According to Wall Street analysts, the average 1-year price target for BIO.B is 363.55 USD with a low forecast of 329.56 USD and a high forecast of 395.33 USD.

What is Bio Rad Laboratories Inc's Revenue forecast?
Projected CAGR
1%

For the last 13 years the compound annual growth rate for Bio Rad Laboratories Inc's revenue is 2%. The projected CAGR for the next 4 years is 1%.

What is Bio Rad Laboratories Inc's Operating Income forecast?
Projected CAGR
7%

For the last 13 years the compound annual growth rate for Bio Rad Laboratories Inc's operating income is 0%. The projected CAGR for the next 3 years is 7%.

Back to Top